Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial (Q40163779)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial |
scientific article |
Statements
1 reference
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial (English)
1 reference
Roy S Herbst
1 reference
Julian Molina
1 reference
Paul Baas
1 reference
Dong-Wan Kim
1 reference
Ji-Youn Han
1 reference
Joo-Hang Kim
1 reference
Catherine Dubos Arvis
1 reference
Myung-Ju Ahn
1 reference
Margarita Majem
1 reference
Mary J Fidler
1 reference
Gilberto de Castro
1 reference
Marcelo Garrido
1 reference
Gregory M Lubiniecki
1 reference
Yue Shentu
1 reference
Ellie Im
1 reference
Marisa Dolled-Filhart
1 reference
Edward B Garon
1 reference
18 December 2015
1 reference
1 reference
1540-1550
1 reference
Identifiers
1 reference